Skip to main content
. 2020 Jun 17;10:9868. doi: 10.1038/s41598-020-66789-x

Figure 7.

Figure 7

LXN is required for the therapeutic effect of retinoic acid on DSS colitis. (A) Experimental protocol for the induction of the acute colitis model and treated with 20 mg/kg retinoic acid in LXN−/− (KO) and littermate LXN+/+ (WT) mice. (B) Changes in body weight of DSS induced WT and KO mice without or with retinoic acid treated (relative to starting weight, set as 100%) is shown (n = 12). (C) The gross morphology of shortened colon was photograph and the colon length was measured at day 7 (n = 4-6). (D) The expression of LXN in colon tissue in WT mice treated with retinoic acid was determined by Western blot. (E) The expression of cytokines in colon tissues from DSS induced WT and KO mice treated with retinoic acid were determined by qPCR (n = 6). (F) Representative images of H&E-stained colons from DSS-induced WT and KO mice treated with retinoic acid are shown. Scale bars = 100 μm. The results shown are the mean ± SEM. A two-tailed unpaired t-test was used to compare experimental groups. *p < 0.05; **p < 0.01; n.s, no significant.